Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT
出版年份 2016 全文链接
标题
Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT
作者
关键词
Pemetrexed, Cisplatin, Chemotherapy, Resistance, Non-small cell lung cancer, Stem cells, EMT
出版物
BMC CANCER
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-02-19
DOI
10.1186/s12885-016-2117-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells
- (2015) Norashikin Zakaria et al. BMC CANCER
- Molecular Portraits of Epithelial, Mesenchymal, and Hybrid States in Lung Adenocarcinoma and Their Relevance to Survival
- (2015) M. J. Schliekelman et al. CANCER RESEARCH
- Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival
- (2015) Anne Grosse-Wilde et al. PLoS One
- Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer
- (2015) S-Q Liang et al. Cell Death & Disease
- Different gap junction-propagated effects on cisplatin transfer result in opposite responses to cisplatin in normal cells versus tumor cells
- (2015) Yuan Zhang et al. Scientific Reports
- Inhibition of REV3 Expression Induces Persistent DNA Damage and Growth Arrest in Cancer Cells
- (2015) Philip A. Knobel et al. NEOPLASIA
- 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
- (2014) B. Besse et al. ANNALS OF ONCOLOGY
- Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer
- (2014) Donatella Del Bufalo et al. Molecular Cancer
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Persistently stalled replication forks inhibit nucleotide excision repair in trans by sequestering Replication protein A
- (2014) Anastasia Tsaalbi-Shtylik et al. NUCLEIC ACIDS RESEARCH
- Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
- (2014) Zhongquan Zhao et al. PLoS One
- Wilms' Tumor Protein Induces an Epithelial-Mesenchymal Hybrid Differentiation State in Clear Cell Renal Cell Carcinoma
- (2014) Valerie B. Sampson et al. PLoS One
- Uracil DNA glycosylase (UNG) loss enhances DNA double strand break formation in human cancer cells exposed to pemetrexed
- (2014) L D Weeks et al. Cell Death & Disease
- MicroRNA-34a: a potential therapeutic target in human cancer
- (2014) X J Li et al. Cell Death & Disease
- Oncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates
- (2013) Kai J. Neelsen et al. JOURNAL OF CELL BIOLOGY
- Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer
- (2013) Masafumi Takeshita et al. LUNG CANCER
- Causes and consequences of replication stress
- (2013) Michelle K. Zeman et al. NATURE CELL BIOLOGY
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
- (2013) Martin P. Barr et al. PLoS One
- MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination
- (2013) M. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest
- (2013) L Lundholm et al. Cell Death & Disease
- Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity
- (2012) S Akunuru et al. Cell Death & Disease
- Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
- (2011) M Bartucci et al. CELL DEATH AND DIFFERENTIATION
- Sustained activation of ERK and Cdk2/cyclin-A signaling pathway by pemetrexed leading to S-phase arrest and apoptosis in human non-small cell lung cancer A549 cells
- (2011) Tsung-Ying Yang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials
- (2011) Joseph Treat et al. LUNG CANCER
- Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways
- (2011) Tsung-Ying Yang et al. MOLECULAR CARCINOGENESIS
- Reduced Level of Ribonucleotide Reductase R2 Subunits Increases Dependence on Homologous Recombination Repair of Cisplatin-Induced DNA Damage
- (2011) Z. P. Lin et al. MOLECULAR PHARMACOLOGY
- SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells
- (2011) C Canino et al. ONCOGENE
- A comparative analysis of the cell biology of senescence and aging
- (2009) Eun Seong Hwang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
- (2009) Francis Rodier et al. NATURE CELL BIOLOGY
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- Base Excision by Thymine DNA Glycosylase Mediates DNA-Directed Cytotoxicity of 5-Fluorouracil
- (2009) Christophe Kunz et al. PLOS BIOLOGY
- Kinetics of H2AX phosphorylation after exposure to cisplatin
- (2008) Peggy L. Olive et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cβ inhibitor, in non-small cell lung cancer cells
- (2008) Floriana Morgillo et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started